These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19586829)

  • 21. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis.
    Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF
    Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of the distribution of zinc and cadmium in cellular fractions of BPH, normal prostate and prostatic cancers of different histologies by atomic and laser absorption spectrometry in tissue slices.
    Feustel A; Wennrich R
    Urol Res; 1984; 12(5):253-6. PubMed ID: 6083653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of cadmium and lead with antioxidant status and incidence of benign prostatic hyperplasia in patients of Western India.
    Pandya C; Gupta S; Pillai P; Bhandarkar A; Khan A; Bhan A; Prajapati A; Gupta S
    Biol Trace Elem Res; 2013 Jun; 152(3):316-26. PubMed ID: 23479318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues].
    Wang FL; Wang H; Qin WJ; Wu GJ; Zhang G; Li KN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):203-5. PubMed ID: 15191726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen.
    Moussa M; Kloth D; Peers G; Cherian MG; Frei JV; Chin JL
    Clin Invest Med; 1997 Dec; 20(6):371-80. PubMed ID: 9413634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of obesity markers and adipocytokines in high grade and high stage prostate cancer in North Indian men - a cross-sectional study.
    Tewari R; Rajender S; Natu SM; Goel A; Dalela D; Goel MM; Tondon P
    Cytokine; 2013 Aug; 63(2):130-4. PubMed ID: 23669251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
    Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cadmium accumulation and metallothionein overexpression in internal spermatic vein of patients with varicocele.
    Jeng SY; Wu SM; Lee JD
    Urology; 2009 Jun; 73(6):1231-5. PubMed ID: 19362335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Pb, Cd, and Se concentrations and oxidative damage-related markers in different grades of prostate carcinoma.
    Guzel S; Kiziler L; Aydemir B; Alici B; Ataus S; Aksu A; Durak H
    Biol Trace Elem Res; 2012 Jan; 145(1):23-32. PubMed ID: 21809052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcript profiling of the androgen signal in normal prostate, benign prostatic hyperplasia, and prostate cancer.
    Bauman DR; Steckelbroeck S; Peehl DM; Penning TM
    Endocrinology; 2006 Dec; 147(12):5806-16. PubMed ID: 16959841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma.
    Iacopino F; Angelucci C; Lama G; Zelano G; La Torre G; D'Addessi A; Giovannini C; Bertaccini A; Macaluso MP; Martorana G; Sica G
    Anticancer Res; 2006; 26(3A):1849-54. PubMed ID: 16827116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression and significance of clusterin in normal prostate, benign prostate hyperplasia and prostate cancer].
    Zhou LQ; Yang XZ; Zeng L; Liang LL; Yang XY; Ren L; Chung L; Zhang ZW; Na YQ; Gu FL; Guo YL
    Zhonghua Wai Ke Za Zhi; 2003 Feb; 41(2):93-5. PubMed ID: 12783666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue-specific cadmium and metallothionein levels in rainbow trout chronically acclimated to waterborne or dietary cadmium.
    Chowdhury MJ; Baldisserotto B; Wood CM
    Arch Environ Contam Toxicol; 2005 Apr; 48(3):381-90. PubMed ID: 15750771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and regulation of metallothionein mRNA levels in the prostates of noble rats: lack of expression in the ventral prostate and regulation by sex hormones in the dorsolateral prostate.
    Ghatak S; Oliveria P; Kaplan P; Ho SM
    Prostate; 1996 Aug; 29(2):91-100. PubMed ID: 8700805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia.
    Jackson MW; Bentel JM; Tilley WD
    J Urol; 1997 Jun; 157(6):2323-8. PubMed ID: 9146664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
    Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
    Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
    Mendoza P; Sánchez C; Contreras HR; Vergara J; Acevedo C; Cabezas J; Huidobro C; Noé G; Castellón EA
    Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different perforin expression in peripheral blood and prostate tissue in patients with benign prostatic hyperplasia and prostate cancer.
    Tokmadžić VS; Tomaš MI; Sotošek S; Laškarin G; Dominović M; Tulić V; Dorđević G; Sustić A; Mrakovčić-Šutić I
    Scand J Immunol; 2011 Oct; 74(4):368-76. PubMed ID: 21535078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation.
    Descazeaud A; Weinbreck N; Robert G; Vacherot F; Abbou CC; Labrousse F; Allory Y; Rubin MA; de la Taille A
    BJU Int; 2011 Jul; 108(2 Pt 2):E23-8. PubMed ID: 20840324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.